More recent, better designed studies have weakened links between antidiabetes medications and cancer risk-Reference-Cited by-同舟云学术

More recent, better designed studies have weakened links between antidiabetes medications and cancer risk

Published:2020-01-03 Issue:2 Volume:37 Page:194-202
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Dankner R.¹²³^ORCID,Roth J.⁴⁵⁶^ORCID

Affiliation:

1. Unit for Cardiovascular Epidemiology Gertner Institute for Epidemiology and Health Policy Research Sheba Medical Centre Ramat Gan Israel

2. Sackler Faculty of Medicine School of Public Health Department of Epidemiology and Preventive Medicine Tel Aviv University Ramat Aviv Tel Aviv Israel

3. Patient Oriented Research Feinstein Institute for Medical ResearchNorth Shore NY USA

4. Laboratory of Diabetes and Diabetes‐Related Disorders North Shore NY USA

5. Centre for Biomedical Science and Centre for Bioelectric Medicine Feinstein Institute for Medical Research Manhasset Northwell Health North Shore NY USA

6. Department of Medicine Albert Einstein College of Medicine New York NY USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14179

Reference49 articles.

1. Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults

2. The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials

3. Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

4. Repurposing metformin for the prevention of cancer and cancer recurrence

5. Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between sodium‐glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real‐world evidence study;Diabetes/Metabolism Research and Reviews;2024-02-25

2. New 1,3,4-Thiadiazole Derivatives as α-Glucosidase Inhibitors: Design, Synthesis, DFT, ADME, and In Vitro Enzymatic Studies;ACS Omega;2024-02-05

3. Targeting the Metabolic Paradigms in Cancer and Diabetes;Biomedicines;2024-01-17

4. Diabetes and Cancer;Textbook of Diabetes;2024-01-12

5. Efficacy of Bee Products (Anzer Honey, Pollen and Propolis) in Detection and Healing of Damage Induced by Antidiabetic Drug Vildagliptin/Metformin Hydrochloride in Healthy Human Pancreatic Cells: Cytotoxic, Genotoxic and Biochemical Studies;Current Medical Science;2023-12